Cargando…

Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade

INTRODUCTION: Rheumatoid arthritis (RA) is a chronic disease associated with inflammation and destruction of bone and cartilage. Although inhibition of TNFα is widely used to treat RA, a significant number of patients do not respond to TNFα blockade, and therefore there is a compelling need to conti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gompels, Luke L, Malik, Nasser M, Madden, Leigh, Jin, Pei, Feldmann, Marc, Shepard, H Michael, Paleolog, Ewa M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308094/ https://www.ncbi.nlm.nih.gov/pubmed/21982514 http://dx.doi.org/10.1186/ar3480

Ejemplares similares

Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade
por: Kaneko, Kazuyo, et al.
Publicado: (2016)

Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition
por: Bainbridge, John, et al.
Publicado: (2007)

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity
Publicado: (1989)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

A window on disease pathogenesis and potential therapeutic strategies: molecular imaging for arthritis
por: Gompels, Luke L, et al.
Publicado: (2011)

Tumour necrosis factor blockade and the risk of osteoporosis: back to the future
por: Sambrook, Philip
Publicado: (2007)

Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors
por: Pilbeam, Kristy, et al.
Publicado: (2017)

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization
por: Gee, Julia MW, et al.
Publicado: (2003)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Central nervous system effects of tumor necrosis factor alpha blockade
por: Schett, Georg
Publicado: (2011)

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2020)

Tumor necrosis factor-α blockade ameliorates diabetic nephropathy in rats
por: Cheng, Dongsheng, et al.
Publicado: (2019)

Tumor necrosis factor-alpha blockade suppresses BK polyomavirus replication
por: Li, Yi-Jung, et al.
Publicado: (2022)

Cell-type specific potent Wnt signaling blockade by bispecific antibody
por: Lee, Nam-Kyung, et al.
Publicado: (2018)

Abrogation of Rb Tumor Suppression Initiates GBM in Differentiated Astrocytes by Driving a Progenitor Cell Program
por: Adhikari, Amit S., et al.
Publicado: (2022)

Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
por: Choe, Deborah, et al.
Publicado: (2023)

Tumor Necrosis Factor Alpha Blockade and Multiple Sclerosis: Exploring New Avenues
por: Zahid, Maryam, et al.
Publicado: (2021)

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer
por: Azria, D, et al.
Publicado: (2003)

Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis
por: Zhang, Hongjun, et al.
Publicado: (2022)

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)
por: Dandekar, P, et al.
Publicado: (2015)

Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
por: Kobold, Sebastian, et al.
Publicado: (2018)

Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor × c-MET Bispecific Antibody
por: Jarantow, Stephen W., et al.
Publicado: (2015)

Blockade of CNG channels abrogates urethral relaxation induced by soluble guanylate cyclase activation
por: Triguero, Domingo, et al.
Publicado: (2009)

Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
por: Ernestam, Sofia, et al.
Publicado: (2006)

Penning trap mass spectrometry of neutron-deficient Rb and Sr isotopes
por: Otto, T, et al.
Publicado: (1991)

Penning trap mass measurements of neutron-deficient Rb and Sr isotopes
por: Otto, T, et al.
Publicado: (1993)

Pseudorabies Virus UL24 Abrogates Tumor Necrosis Factor Alpha-Induced NF-κB Activation by Degrading P65
por: Wang, Tong-Yun, et al.
Publicado: (2020)

Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity
por: Dheilly, Elie, et al.
Publicado: (2018)

Synergetic protective effect of berberine and ginsenoside Rb1 against tumor necrosis factor alpha−induced inflammation in adipocytes
por: Cai, Zhixing, et al.
Publicado: (2021)

Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte
por: Klooster, Aaron R, et al.
Publicado: (2005)

Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade
por: Kwong, Tsz Tung, et al.
Publicado: (2020)

Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis
por: Choi, Yeon-Sook, et al.
Publicado: (2022)

Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A
por: Zheng, Songmao, et al.
Publicado: (2020)

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014)

AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways
por: Yin, Wei, et al.
Publicado: (2021)

Use of CD200 blockade inhibitor to enhance glioma immunotherapy
por: Mesias, Elisabet, et al.
Publicado: (2015)

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
por: Dheilly, Elie, et al.
Publicado: (2017)

A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A
por: Xu, Tianshu, et al.
Publicado: (2017)

To Rb or not to Rb
por: Wells, William A.
Publicado: (2002)

Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r0kbcagtee4pi0rbiu1rpgb8oj